🔬 Dr. Shuwei Zhou is a distinguished researcher specializing in imaging and nuclear medicine at Zhongda Hospital, Southeast University, China. 🏥 She holds a Ph.D. in Imaging and Nuclear Medicine from Southeast University and a B.A. & Master’s from Hunan University of Chinese Medicine. 🎓 Dr. Zhou has authored numerous high-impact SCI publications 📑 focusing on HCC, LI-RADS, MRI diagnostics, and treatment response. Her contributions include 4 national research projects and 2 patents. 🏆 As a leading expert in radiology and medical imaging, her work advances diagnostic accuracy and patient care in oncology and musculoskeletal disorders. ⚕️✨

Publication Profile

Scopus

Education

Ms. Shuwei Zhou 🎓 has showcased outstanding academic excellence, earning a Ph.D. in Imaging and Nuclear Medicine from the School of Medicine at Southeast University 🏥. Her strong foundation in the field began at Hunan University of Chinese Medicine, where she completed her B.A. and Master’s degree, ranking 1st out of 159 students 🏆. With expertise in molecular and functional imaging, interventional radiology, and pathology 🔬, she has developed a deep understanding of advanced medical diagnostics. Her dedication to research and innovation continues to shape the future of nuclear medicine and imaging technology. 🚀

Experience 

Ms. Shuwei Zhou 🔬 has made significant research contributions, publishing in esteemed journals like the American Journal of Roentgenology, Abdominal Radiology, and Frontiers in Immunology 📚. As the first author, she has led groundbreaking studies on MRI contrast agents, diagnostic performance, and treatment response in hepatocellular carcinoma (HCC) 🏥. Her interdisciplinary expertise extends to osteoporosis prediction, the role of gut microbiota in inflammatory bowel disease, and dual-energy CT for bone mineral density 🦴. Through her innovative research, she continues to advance medical imaging and diagnostic precision, making a lasting impact on the field of nuclear medicine. 🚀

Awards

Ms. Shuwei Zhou 🎓 is a distinguished researcher whose impressive portfolio includes first-author contributions in high-impact journals, leadership in scientific projects, and remarkable interdisciplinary expertise 🔬. Her groundbreaking work in imaging and nuclear medicine, particularly in hepatocellular carcinoma research and diagnostic imaging techniques 🏥, has significantly advanced the field. With a strong commitment to innovation and precision in medical diagnostics, she continues to push the boundaries of research. Her achievements make her a highly deserving candidate for the Best Researcher Award 🏆, recognizing her invaluable contributions to the future of medical imaging and nuclear medicine. 🚀

Research Focus

Shuwei Zhou’s research primarily focuses on medical imaging 🏥📡 and oncology, with a particular emphasis on hepatocellular carcinoma (HCC) 🏨🧬 and non-radiation treatment response assessment. She is actively involved in the development of diagnostic algorithms 📊🔍, such as the LI-RADS Nonradiation Treatment Response Algorithm, and predictive models like the TRACE Model, which help evaluate the effectiveness of transarterial chemoembolization (TACE) 💉⚕️ in patients with unresectable liver cancer. Her contributions aim to enhance precision medicine 🎯 and optimize clinical decision-making for better patient outcomes.

Publication Top Notes